Gout
📧 Sign up to get email alerts when something new happens for Gout.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-01-09Clinical Trial Update: Single and Multiple Dose Study in Japanese Subjects [Phase 1]
Phase 1 single and multiple dose study in Japanese subjects for gout-related lesinurad has completed.
-
FDA approval · 2013-12-12FDA Approved: ULORIC — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ULORIC (febuxostat) by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency [Phase 2]
A completed Phase 2 randomized, double-blind dose–response study evaluated the safety and uric acid–lowering effects of oral ulodesine added…
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral Ulodesine Added to Allopurinol [Phase 2]
A Phase 2 trial evaluating the uric acid-lowering activity, safety, and efficacy of adding ulodesine to allopurinol in patients with gout an…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: NSAID Drug Interaction Study [Phase 1]
Phase 1 study evaluating potential NSAID interactions in gout has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-10-10FDA Approved: KRYSTEXXA — Supplemental Application (Horizon Therapeutics USA, Inc.)
FDA approved a supplemental Biologics License Application for Krystexxa (pegloticase) submitted by Horizon Therapeutics USA, Inc. The action…
-
CLINICAL_TRIALS trial_result · 2013-09-25Clinical Trial Update: Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment [Phase 2]
Phase 2 trial evaluating the effect of febuxostat on renal function in patients with gout and moderate to severe renal impairment; results p…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Single and Multiple Dose Study in Japanese [Phase 1]
A Phase 1 single and multiple dose study conducted in Japanese subjects for gout has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-11Clinical Trial Update: Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of LC350189 [Phase 1]
Phase 1 study of the investigational agent LC350189 in hyperuricemia and gout assessing safety, tolerability, and pharmacokinetic/pharmacody…
-
CLINICAL_TRIALS trial_result · 2013-06-03Clinical Trial Update: A Study of Persons With Gout Who Do Not Respond to or Are Allergic to Conventional Therapy [Phase 2]
The document reports the completion of a Phase 2 trial in gout patients who do not respond to or are allergic to conventional therapy.
-
FDA approval · 2013-05-06FDA Approved: ALLOPURINOL — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's original application for the generic drug allopurinol. Allopurinol is used to treat gout and to lower uric …
-
CLINICAL_TRIALS trial_result · 2013-04-25Clinical Trial Update: Effects of Green Tea on Level of Serum Uric Acid in Healthy Individuals [NA]
A completed clinical trial investigated whether green tea affects serum uric acid levels in healthy individuals. The study relates to hyperu…
-
CLINICAL_TRIALS research · 2013-03-12Clinical Trial Update: Italian Observational Study Assessing the Impact of Gout on Patients Disability and Quality of Life
This clinical trial update reports the completion of an Italian observational study evaluating how gout impacts disability and quality of li…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: The Blood Pressure Effects of Febuxostat in Patients Previously Treated With Allopurinol: A Pilot Study [NA]
A pilot study evaluating the blood pressure effects of febuxostat in patients previously treated with allopurinol; the trial is terminated w…
-
FDA approval · 2013-02-07FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to add Aleve GelCaps (naproxen sodium) as a new dosage form for the Aleve product line, expanding th…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Pegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory Gout [Phase 2]
This update covers a Phase 2 trial of pegylated recombinant uricase (PEG-uricase) for refractory gout, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Efficacy and Safety of a Single Dose of Canakinumab (ACZ885) in Hospitalized Patients With Acute Gout [Phase 2]
Phase 2 trial results evaluating a single dose of canakinumab for efficacy and safety in hospitalized patients with acute gout.
-
FDA approval · 2012-11-01FDA Approved: ULORIC — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for ULORIC (febuxostat) from Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2012-09-28FDA Approved: INDOMETHACIN — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' indomethacin as an original ANDA (generic) application, making Indomethacin available as a generic …
-
FDA approval · 2012-06-13FDA Approved: NAPROXEN SODIUM — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Naproxen Sodium from Bionpharma Inc., updating the product's regulatory approval.
-
FDA approval · 2012-04-16FDA Approved: KRYSTEXXA — Supplemental Application (Horizon Therapeutics USA, Inc.)
FDA approved a supplemental application for KRYSTEXXA (pegloticase) from Horizon Therapeutics USA, Inc.
-
CLINICAL_TRIALS trial_result · 2012-03-27Clinical Trial Update: Clinical Study to Evaluate the Pharmacokinetic Characteristics Between TMX-67 and Feburic® in Healthy Volunteers [Phase 1]
Phase 1 pharmacokinetic study comparing TMX-67 with Feburic (febuxostat) in healthy volunteers has been completed.
-
FDA approval · 2012-03-15FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to add Aleve GelCaps containing naproxen sodium, expanding the approval to include a new dosage form…
-
CLINICAL_TRIALS research · 2012-03-07Clinical Trial Update: Assessment of Primary Care Providers' Knowledge and Beliefs Regarding Gout Management
A completed clinical trial evaluating primary care providers' knowledge and beliefs regarding gout management.
-
CLINICAL_TRIALS trial_result · 2012-01-27Clinical Trial Update: Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout [Phase 2]
A Phase 2 clinical trial evaluating Levotofisopam 50 mg three times daily for 7 days in patients with hyperuricemia and gout. The study stat…